Results 171 to 180 of about 20,678 (258)

Incretin‐Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice

Obesity Reviews, EarlyView.
ABSTRACT Introduction Pregnancy concurrent with incretin‐based medications is contraindicated due to unknown risk of teratogenicity, as is breastfeeding. The aim of this systematic scoping review was to investigate potential risks and benefits of incretin‐based medications in relation to preconception, pregnancy, and postnatal health, and to propose ...
Kate Maslin, Jill Shawe, Sinead Blowers, Michael Ceulemans, Kathryn Hart, Sam Schoenmakers, Amihai Rottenstreich, Heather Hopper, Mojca Jensterle, Angela C. Flynn, Sarah Siegelaar, Annick Bogaerts, Isy Douek, Nicola Heslehurst, Dries Ceulemans, Tricia Tan, Johnathan Pinkney, Martin Whyte, Shahrad Taheri, Roland Devlieger   +19 more
wiley   +1 more source

Treatment preference for once-weekly versus once-daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med
Xie X, Chen Y, Wang P, Hu M.
europepmc   +1 more source

Drug‐Induced Sialolithiasis—A Big‐Data Retrospective Study

Oral Diseases, EarlyView.
ABSTRACT Background Sialolithiasis pathophysiology is multifactorial, with systemic medications often hypothesised as a key contributor, particularly in older adults (Drug‐Induced Sialolithiasis). However, robust evidence supporting this theory is limited.
Gal Avishai, Gil Caspi, Akhilanand Chaurasia, Gavriel Chaushu, Daya Masri, Ehud Jonas   +5 more
wiley   +1 more source

Imeglimin and DPP-4 inhibitors: A promising therapeutic strategy for type 2 diabetes individuals with reduced insulin secretion. [PDF]

Diabetes Obes Metab
Hamamoto Y, Usui R.
europepmc   +1 more source

Hyperkalemia and maintenance of renin-angiotensin system inhibitor therapy after initiating SGLT-2 or DPP-4 inhibitors. [PDF]

Nephrol Dial Transplant
Bosi A, Xu Y, Faucon AL, Huang T, Evans M, Shin JI, Fu EL, Carrero JJ.   +7 more
europepmc   +1 more source

Corn tolerance and weed control with amicarbazone and metribuzin applied preemergence

Agrosystems, Geosciences &Environment, Volume 9, Issue 3, September 2026.
Abstract Since the late 1950s, atrazine has been a cornerstone of corn (Zea mays L.) weed control, but decades of use have raised concerns about groundwater contamination and enhanced biodegradation. Therefore, amicarbazone and metribuzin were evaluated as alternatives to preemergence use of atrazine in corn.
Michael R. Dodde, Jason K. Norsworthy, Tom Barber, Ryan S. Henry   +3 more
wiley   +1 more source

Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis. [PDF]

Front Pharmacol
He L, Li J, Cheng X, Luo L, Huang Y.
europepmc   +1 more source

Improvement of Glycemia by DPP-4 Inhibitors

Journal of the Japan Diabetes Society, 2013
Nishi, Y., Fujimoto, S.
openaire   +1 more source

Effects of Oral Semaglutide on Dietary Intake and Body Composition in Japanese People With Type 2 Diabetes: A Prospective Observational Study in Clinical Practice

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
This prospective observational study evaluated changes in dietary patterns and body composition after 3 months of oral semaglutide treatment in people with Type 2 diabetes. Oral semaglutide was associated with reduced energy intake, salt intake and body fat while preserving handgrip strength.
Mika Sawada, Naoko Nakanishi, Masakazu Aihara, Kanako Ohkuma, Shoko Hamano, Yoshitaka Sakurai, Rie Sekine, Satoshi Usami, Toshimasa Yamauchi, Naoto Kubota   +9 more
wiley   +1 more source

Therapeutic Effects of GLP-1 Receptor Agonists and DPP-4 Inhibitors in Neuropathic Pain: Mechanisms and Clinical Implications. [PDF]

Biomolecules
Kuthati Y, Davuluri VNG, Wong CS.
europepmc   +1 more source